dope doctors tirzepatide Obesity drug seen as effective for long COVID, gets clinical trial ✨ I lost 25 pounds

Editors Note: The immune system is a viciously complex topic

The second ongoing trial (NCT06029972, PALEKONA) is testing tilpisertib fosmecarbil (GS-5290), a prodrug formulation, in a dose-ranging study with three active doses versus placebo, targeting 176 participants with the primary endpoint being clinical response per modified MS at Week 12

Serpina3n limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leucocyte elastase

PlexusDx supports precision-wellness approaches that combine clinical evidence with individual biomarker context to help you and your provider make informed adjustments

Mazdutide (Innovent Biologics) is another dual GLP-1/glucagon agonist showing promising results in Chinese patient populations